Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer

BackgroundPyruvate dehydrogenase (PDH) complex converts pyruvate into acetyl-CoA by pyruvate decarboxylation, which drives energy metabolism during cell growth, including prostate cancer (PCa) cell growth. The major catalytic subunit of PDH, PDHA1, is regulated by phosphorylation/dephosphorylation b...

Full description

Bibliographic Details
Main Authors: Caroline E. Nunes-Xavier, Janire Mingo, Maite Emaldi, Karine Flem-Karlsen, Gunhild M. Mælandsmo, Øystein Fodstad, Roberto Llarena, José I. López, Rafael Pulido
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.873516/full
_version_ 1811255758685208576
author Caroline E. Nunes-Xavier
Caroline E. Nunes-Xavier
Janire Mingo
Maite Emaldi
Karine Flem-Karlsen
Gunhild M. Mælandsmo
Øystein Fodstad
Roberto Llarena
José I. López
José I. López
Rafael Pulido
Rafael Pulido
author_facet Caroline E. Nunes-Xavier
Caroline E. Nunes-Xavier
Janire Mingo
Maite Emaldi
Karine Flem-Karlsen
Gunhild M. Mælandsmo
Øystein Fodstad
Roberto Llarena
José I. López
José I. López
Rafael Pulido
Rafael Pulido
author_sort Caroline E. Nunes-Xavier
collection DOAJ
description BackgroundPyruvate dehydrogenase (PDH) complex converts pyruvate into acetyl-CoA by pyruvate decarboxylation, which drives energy metabolism during cell growth, including prostate cancer (PCa) cell growth. The major catalytic subunit of PDH, PDHA1, is regulated by phosphorylation/dephosphorylation by pyruvate dehydrogenase kinases (PDKs) and pyruvate dehydrogenase phosphatases (PDPs). There are four kinases, PDK1, PDK2, PDK3 and PDK4, which can phosphorylate and inactivate PDH; and two phosphatases, PDP1 and PDP2, that dephosphorylate and activate PDH.MethodsWe have analyzed by immunohistochemistry the expression and clinicopathological correlations of PDHA1, PDP1, PDP2, PDK1, PDK2, PDK3, and PDK4, as well as of androgen receptor (AR), in a retrospective PCa cohort of patients. A total of 120 PCa samples of representative tumor areas from all patients were included in tissue microarray (TMA) blocks for analysis. In addition, we studied the subcellular localization of PDK2 and PDK3, and the effects of the PDK inhibitor dichloroacetate (DCA) in the growth, proliferation, and mitochondrial respiration of PCa cells.ResultsWe found heterogeneous expression of the PDH complex components in PCa tumors. PDHA1, PDP1, PDK1, PDK2, and PDK4 expression correlated positively with AR expression. A significant correlation of PDK2 immunostaining with biochemical recurrence and disease-free survival was revealed. In PCa tissue specimens, PDK2 displayed cytoplasmic and nuclear immunostaining, whereas PDK1, PDK3 and PDK4 showed mostly cytoplasmic staining. In cells, ectopically expressed PDK2 and PDK3 were mainly localized in mitochondria compartments. An increase in maximal mitochondrial respiration was observed in PCa cells upon PDK inhibition by DCA, in parallel with less proliferative capacity.ConclusionOur findings support the notion that expression of specific PDH complex components is related with AR signaling in PCa tumors. Furthermore, PDK2 expression associated with poor PCa prognosis. This highlights a potential for PDH complex components as targets for intervention in PCa.
first_indexed 2024-04-12T17:29:44Z
format Article
id doaj.art-060cb01a32194d9ab44dea2f0e95b000
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T17:29:44Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-060cb01a32194d9ab44dea2f0e95b0002022-12-22T03:23:10ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-05-011210.3389/fonc.2022.873516873516Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate CancerCaroline E. Nunes-Xavier0Caroline E. Nunes-Xavier1Janire Mingo2Maite Emaldi3Karine Flem-Karlsen4Gunhild M. Mælandsmo5Øystein Fodstad6Roberto Llarena7José I. López8José I. López9Rafael Pulido10Rafael Pulido11Biomarkers in Cancer, Biocruces Bizkaia Health Research Institute, Barakaldo, SpainDepartment of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, NorwayBiomarkers in Cancer, Biocruces Bizkaia Health Research Institute, Barakaldo, SpainBiomarkers in Cancer, Biocruces Bizkaia Health Research Institute, Barakaldo, SpainDepartment of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, NorwayDepartment of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, NorwayDepartment of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, NorwayDepartment of Urology, Cruces University Hospital, Barakaldo, SpainBiomarkers in Cancer, Biocruces Bizkaia Health Research Institute, Barakaldo, SpainDepartment of Pathology, Cruces University Hospital, Barakaldo, SpainBiomarkers in Cancer, Biocruces Bizkaia Health Research Institute, Barakaldo, SpainIkerbasque, Basque Foundation for Science, Bilbao, SpainBackgroundPyruvate dehydrogenase (PDH) complex converts pyruvate into acetyl-CoA by pyruvate decarboxylation, which drives energy metabolism during cell growth, including prostate cancer (PCa) cell growth. The major catalytic subunit of PDH, PDHA1, is regulated by phosphorylation/dephosphorylation by pyruvate dehydrogenase kinases (PDKs) and pyruvate dehydrogenase phosphatases (PDPs). There are four kinases, PDK1, PDK2, PDK3 and PDK4, which can phosphorylate and inactivate PDH; and two phosphatases, PDP1 and PDP2, that dephosphorylate and activate PDH.MethodsWe have analyzed by immunohistochemistry the expression and clinicopathological correlations of PDHA1, PDP1, PDP2, PDK1, PDK2, PDK3, and PDK4, as well as of androgen receptor (AR), in a retrospective PCa cohort of patients. A total of 120 PCa samples of representative tumor areas from all patients were included in tissue microarray (TMA) blocks for analysis. In addition, we studied the subcellular localization of PDK2 and PDK3, and the effects of the PDK inhibitor dichloroacetate (DCA) in the growth, proliferation, and mitochondrial respiration of PCa cells.ResultsWe found heterogeneous expression of the PDH complex components in PCa tumors. PDHA1, PDP1, PDK1, PDK2, and PDK4 expression correlated positively with AR expression. A significant correlation of PDK2 immunostaining with biochemical recurrence and disease-free survival was revealed. In PCa tissue specimens, PDK2 displayed cytoplasmic and nuclear immunostaining, whereas PDK1, PDK3 and PDK4 showed mostly cytoplasmic staining. In cells, ectopically expressed PDK2 and PDK3 were mainly localized in mitochondria compartments. An increase in maximal mitochondrial respiration was observed in PCa cells upon PDK inhibition by DCA, in parallel with less proliferative capacity.ConclusionOur findings support the notion that expression of specific PDH complex components is related with AR signaling in PCa tumors. Furthermore, PDK2 expression associated with poor PCa prognosis. This highlights a potential for PDH complex components as targets for intervention in PCa.https://www.frontiersin.org/articles/10.3389/fonc.2022.873516/fullprostate cancer (PCa)pyruvate dehydrogenase (PDH)pyruvate dehydrogenase kinase (PDK)androgen receptor (AR)dichloroacetate (DCA)
spellingShingle Caroline E. Nunes-Xavier
Caroline E. Nunes-Xavier
Janire Mingo
Maite Emaldi
Karine Flem-Karlsen
Gunhild M. Mælandsmo
Øystein Fodstad
Roberto Llarena
José I. López
José I. López
Rafael Pulido
Rafael Pulido
Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
Frontiers in Oncology
prostate cancer (PCa)
pyruvate dehydrogenase (PDH)
pyruvate dehydrogenase kinase (PDK)
androgen receptor (AR)
dichloroacetate (DCA)
title Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
title_full Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
title_fullStr Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
title_full_unstemmed Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
title_short Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
title_sort heterogeneous expression and subcellular localization of pyruvate dehydrogenase complex in prostate cancer
topic prostate cancer (PCa)
pyruvate dehydrogenase (PDH)
pyruvate dehydrogenase kinase (PDK)
androgen receptor (AR)
dichloroacetate (DCA)
url https://www.frontiersin.org/articles/10.3389/fonc.2022.873516/full
work_keys_str_mv AT carolineenunesxavier heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT carolineenunesxavier heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT janiremingo heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT maiteemaldi heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT karineflemkarlsen heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT gunhildmmælandsmo heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT øysteinfodstad heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT robertollarena heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT joseilopez heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT joseilopez heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT rafaelpulido heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer
AT rafaelpulido heterogeneousexpressionandsubcellularlocalizationofpyruvatedehydrogenasecomplexinprostatecancer